US Equities Analysis

HON — Honeywell

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 21.0%
Profit Margins 10.89%
Return on Equity 24.26%
Return on Assets 5.95%
Free Float 0.6B
Dividend Yield 2.05%
Short Int % Utilisation 2.18%

2.2 Growth

Metric Value
Revenue Growth 2.4%
Free Cash Flow 2.94B
EBITDA 18.4 (Ratio)
Enterprise Value 156.89B
EV/Revenue 4.17
EV/EBITDA 18.4

Revenue growth of 2.4% suggests mature or challenged top-line momentum.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 15.10%
Risk / Std Dev (Ann.)* 26.73%
1-Year Price Return* 10.99%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $233.96
52-Week Range $195.87 – $260.28
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $37.44B
Prior annual revenue $34.72B
EBIT $6.82B
Tax rate 18.40%
NOPAT = EBIT × (1 − tax rate) $5.57B
Forecast start-growth basis 7.85%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $5.57B
Add: depreciation & amortisation $1.39B
Less: capital expenditure -$986.00M
Less/(add): working-capital cash-flow movement -$352.00M
Current unlevered FCFF $5.62B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 7.85% $6.00B $1.50B -$1.06B -$379.63M $6.06B $5.84B
2 6.51% $6.39B $1.59B -$1.25B -$404.35M $6.33B $5.67B
3 5.17% $6.72B $1.68B -$1.43B -$425.27M $6.54B $5.44B
4 3.84% $6.98B $1.74B -$1.62B -$441.59M $6.67B $5.16B
5 2.50% $7.16B $1.78B -$1.78B -$452.63M $6.70B $4.82B

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 0.92
Cost of equity 9.76%
Pre-tax cost of debt 3.97%
WACC 7.61%
WACC validation within standard range

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $134.39B
Implied terminal EV / EBITDA 12.73x
Terminal value as % of enterprise value 77.57%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $26.93B
Present value of terminal value $93.12B
Indicated enterprise value $120.05B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $120.05B
Less: gross interest-bearing debt $35.56B
Add: cash and equivalents $12.93B
Add: affiliate investments $0.00
Less: minority interests $1.13B
Indicated common equity value $96.30B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 321,400,000.00
Share-count basis reported diluted weighted-average shares
Current market price $228.25
DCF indicative value per share $299.61
Indicative value vs. market price 31.27%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range pass
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% review required

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 4/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:36:36.145636 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

us-equity stock equity hon industrials industrial-conglomerates nasdaq